A. Abotaleb

HTA recommendations for biosimilars implementation in oncology field in MENA region

Background With the presence of concept of biosimilar products at last decade which defined by WHO as a biotherapeutic product which is similar in terms of quality, safe...

A. Abotaleb ;

06/27/2022

Policy analysis for gastrointestinal cancer care in MENA region

Background With rapid population growth, population aging and changing lifestyle at MENA Region (Middle East & North Africa countries) number of newly diagnosed (GI)...

A. Abotaleb ;

06/27/2022

Efficient treatment policies and its impact on the economic burden for CRC in low-middle income countries: the Egypt Case

Introduction The growing burden of cancer in low–resource environments, is increasing the impact on morbidity, mortality and economic cost due to cancer for the next 20 years. Acc...

A. Abotaleb ;

07/01/2019